-
admin
Posts
Oak City Auto Detailing Proudly Announces Launch of Mobile Detailing Services in Raleigh, NC
Raleigh, NC, Nov. 11, 2024 (GLOBE NEWSWIRE) — Oak City Auto Detailing, a leading auto detailing provider, is excited to announce the launch of its...
Toss Securities Appoints Richard J. Hagen as CEO of US Subsidiary TSA Financial LLC
Hagen brings a wealth of experience from financial investment industries from previous roles as CEO of PayPal Invest and co-founder/president of Ally Invest Hagen to take...
Research Reveals Insights into the Impact of Legal Tech on Australian In-House Teams
Digitally mature teams have the highest productivity and the lowest headcount, while digitally immature teams have the lowest productivity, largest teams, and most FTEs. The...
Yalla Group Limited Announces Unaudited Third Quarter 2024 Financial Results
DUBAI, UAE, Nov. 12, 2024 /PRNewswire/ — Yalla Group Limited (“Yalla” or the “Company”) (NYSE: YALA), the largest Middle East and North Africa (MENA)-based online...
SEMIFIVE Collaborates with Synopsys to Develop Advanced Chiplet Platform for High-Performance Multi-Die Designs
The Platform Helps Meet PPA Goals and Accelerate Time-to-Market SEOUL, South Korea, Nov. 12, 2024 /PRNewswire/ — SEMIFIVE, a leading design solution provider and pioneer...
How to turn passion into profit and why half of Aussie start-ups fail
Over 300 Founders and SME leaders set to gather at Melbourne’s Federation Square on 22nd November for launch of ‘The 4Ps of Business’ book MELBOURNE,...
2024 Beijing E-Town Half Marathon Kicks Off, Humanoid Robots Cheering on Runners
BEIJING, Nov. 11, 2024 (GLOBE NEWSWIRE) — On November 10, the 2024 Beijing E-Town Half Marathon began, celebrating the annual blend of technology and sports,...
SpringWorks Therapeutics Announces Mirdametinib Data to be Presented at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting
– Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in health-related quality of life over...
EvolveImmune Therapeutics Presents New Preclinical and Translational Data Highlighting Pipeline Progress for EVOLVE T Cell Engager Platform at 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Poster Presentations Spotlight Differentiated Therapeutic Profile and Precision Therapeutic Strategy for Lead Development Candidate EVOLVE104 as Program Advances Toward Clinic for Solid Tumors EVOLVE Platform...
Avalo Therapeutics to Present at Upcoming Investor Conferences
WAYNE, Pa. and ROCKVILLE, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment...
